BFA Logo Transparent (002).png
LEGAL DEADLINE ALERT: Sprout Social (Nasdaq: SPT) Investors are Encouraged to Contact BFA Law before July Deadline in Securities Class Action after Stock Tumbled Over 40%
May 28, 2024 07:26 ET | Bleichmar Fonti & Auld
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 12, 2024 deadline in the (Nasdaq: SPT) Sprout Social Securities Class Action...
BFA Logo Transparent (002).png
CEREVEL THERAPEUTICS ALERT: Cerevel’s $45 Merger Offer From AbbVie is Under Investigation (Nasdaq: CERE) – Contact BFA Law to Discuss How this Impacts You
May 28, 2024 07:26 ET | Bleichmar Fonti & Auld
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between (Nasdaq: CERE) Cerevel Therapeutics Holdings, Inc. and AbbVie, Inc. If...
22157.jpg
Global Telehealth Services Market Report 2024-2034: CAGR of 30.42% Projected Over the Forecast Period with Doxy.me, Teladoc Health, and Medtronic Dominating
May 28, 2024 07:24 ET | Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Global Telehealth Services Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global...
Atrion Logo.jpg
Atrion Corporation Enters Into Merger Agreement with Nordson Corporation
May 28, 2024 07:24 ET | Atrion Corporation
ALLEN, Texas, May 28, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered...
Sýn hf.: Viðskipti s
Sýn hf.: Viðskipti stjórnenda
May 28, 2024 07:23 ET | Sýn hf.
Sjá meðfylgjandi: Viðhengi Viðskipti stjórnenda_H33 Invest_28.05.2024 ...
Furrever Token logo.PNG
How Bitcoin (BTC)’s Regulation, Ethereum (ETH)’s Updates, and Furrever Token’s Launch Could Transform the Market
May 28, 2024 07:21 ET | Furrever Token
New York City, NY, May 28, 2024 (GLOBE NEWSWIRE) -- The cryptocurrency market is in a constant state of flux, driven by regulatory changes, technological advancements, and the introduction of new...
22157.jpg
The Future of Cannabidiol (CBD) Pain Treatments, 2024: Commercial and Clinical Assessment with Analysis of Pipeline Development Activities
May 28, 2024 07:19 ET | Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Cannabidiol (CBD) Pain - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The medical and pharmaceutical...
22157.jpg
Emerging Opportunities in Low-Carbon Flooring Markets, 2024-2034, Featuring Strategic Analysis of Tarkett, Forbo Sarlino, Mohawk Industries, Shaw Industries Group, Interface, and More
May 28, 2024 07:16 ET | Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Low-Carbon Flooring Market - A Global and Regional Analysis: Focus on Application, Material Type, Design Type, and Region - Analysis and Forecast,...
22157.jpg
Shingles Treatment Pipeline Report 2024: Key Products, Companies, Unmet Needs, Emerging Therapies, Challenges and Opportunities
May 28, 2024 07:13 ET | Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Shingles - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.This report offers comprehensive and strategic insights...
logo.jpg
Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million
May 28, 2024 07:10 ET | Royalty Pharma plc
Vorasidenib, if approved, would be the first targeted therapy in IDH-mutant glioma, a progressive and incurable brain tumorPivotal Phase 3 clinical study of vorasidenib demonstrated unprecedented...